• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MDC 0.00% $6.60

MEDLAB CLINICAL LIMITED - Announcements

Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company focused on... Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company focused on the development and commercialization of a pharmaceutical delivery platform. The Company is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The Company also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.More

Announcements


Filters [Clear]
  • Price Sensitive: Yes
MDC Half Yearly Report and AccountsPRICE SENSITIVE15/05/24 download Created with Sketch. 1.81MB
MDC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/04/24 download Created with Sketch. 343.84KB
MDC MDC Annual Report to shareholdersPRICE SENSITIVE24/04/24 download Created with Sketch. 2.1MB
MDC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 340.71KB
MDC Medlab Settlement of Share Sale DeedPRICE SENSITIVE15/01/24 download Created with Sketch. 121.56KB
MDC MDC HY23 Interim ReportPRICE SENSITIVE09/01/24 download Created with Sketch. 510.57KB
MDC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE08/12/23 download Created with Sketch. 1.09MB
MDC Notice of Extraordinary General Meeting / Proxy FormPRICE SENSITIVE22/11/23 download Created with Sketch. 3.2MB
MDC Shareholder Update - Restructuring TransactionPRICE SENSITIVE09/11/23 download Created with Sketch. 170.22KB
MDC Medlab Update to ShareholdersPRICE SENSITIVE12/09/23 download Created with Sketch. 133.98KB
MDC Medlab Update to ShareholdersPRICE SENSITIVE07/06/23 download Created with Sketch. 101.01KB
MDC Medlab Update to ShareholdersPRICE SENSITIVE21/03/23 download Created with Sketch. 372.95KB
MDC Company Status and Board Composition UpdatesPRICE SENSITIVE16/03/23 download Created with Sketch. 191.22KB
MDC Appointment of External Consultants to MedlabPRICE SENSITIVE06/03/23 download Created with Sketch. 174.6KB
MDC Suspension from Official QuotationPRICE SENSITIVE27/02/23 download Created with Sketch. 86.43KB
MDC Trading HaltPRICE SENSITIVE23/02/23 download Created with Sketch. 438.74KB
MDC Aust ODC Approves NanaDol Export for UK UsePRICE SENSITIVE07/02/23 download Created with Sketch. 152.61KB
MDC Appendix 4C Administrative ClarificationPRICE SENSITIVE01/02/23 download Created with Sketch. 385.58KB
MDC UK Home Office Grants UK Import Certificate for NanaBisPRICE SENSITIVE25/01/23 download Created with Sketch. 155.87KB
MDC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE20/01/23 download Created with Sketch. 381.06KB
MDC Medlab Announces Interim Readout of RWE Medcare StudyPRICE SENSITIVE12/01/23 download Created with Sketch. 208.1KB
MDC Medlab Files Registration Statement for Proposed US IPOPRICE SENSITIVE28/12/22 download Created with Sketch. 173.82KB
MDC NASDAQ Progression - Medlab Clears SEC CommentsPRICE SENSITIVE08/12/22 download Created with Sketch. 151.76KB
MDC First Tranche IP Royalty Payment from PharmacarePRICE SENSITIVE01/12/22 download Created with Sketch. 149.5KB
MDC Medlab receives UK Import Permission from MHRA for NanaBisPRICE SENSITIVE25/11/22 download Created with Sketch. 169.13KB
MDC Jefferies HealthCare Conference NanoCelle PresentationPRICE SENSITIVE16/11/22 download Created with Sketch. 11.15MB
MDC NanoCelle Nasal RNA (Nucleid Acid) Program UpdatePRICE SENSITIVE10/11/22 download Created with Sketch. 158.76KB
MDC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/10/22 download Created with Sketch. 403.82KB
MDC Medlab Received 2022 R&D ClaimPRICE SENSITIVE26/09/22 download Created with Sketch. 162.59KB
MDC Preliminary Final ReportPRICE SENSITIVE30/08/22 download Created with Sketch. 99.26KB
MDC Depression European Patent Accepted, Proceeding to GrantPRICE SENSITIVE10/08/22 download Created with Sketch. 201.84KB
MDC UNSW Medlab Laboratory Collaboration Additional InformationPRICE SENSITIVE02/08/22 download Created with Sketch. 195.48KB
MDC Medlab enters Laboratory Collaboration with UNSW, SydneyPRICE SENSITIVE01/08/22 download Created with Sketch. 153.33KB
MDC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/07/22 download Created with Sketch. 387.97KB
MDC EGM Notice of Meeting to Approve Dual Listing to NasdaqPRICE SENSITIVE29/06/22 download Created with Sketch. 1.05MB
MDC Trading HaltPRICE SENSITIVE28/06/22 download Created with Sketch. 326.8KB
MDC Pause in TradingPRICE SENSITIVE28/06/22 download Created with Sketch. 116.07KB
MDC NanaBis Independently Confirmed BioAvailabilityPRICE SENSITIVE27/06/22 download Created with Sketch. 227.72KB
MDC Medlab signs exclusive commercial agreement with YesHealthPRICE SENSITIVE23/06/22 download Created with Sketch. 136.24KB
MDC Progression of NanoCelle NASAL COVID-19 Vaccine ProgramPRICE SENSITIVE31/05/22 download Created with Sketch. 181.7KB
MDC Medlab Signs NRG Biotic Trade Deal with Cultech LtdPRICE SENSITIVE20/04/22 download Created with Sketch. 201.69KB
MDC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE14/04/22 download Created with Sketch. 3.62MB
MDC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE13/04/22 download Created with Sketch. 3.38MB
MDC Half Yearly Report and AccountsPRICE SENSITIVE24/02/22 download Created with Sketch. 626.22KB
MDC UK Ethics favourable opinion for upcoming NanaBis P3 TrialPRICE SENSITIVE07/02/22 download Created with Sketch. 191.1KB
MDC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE27/01/22 download Created with Sketch. 420.9KB
MDC Medlab Completes Nutraceuticals Divestment to PharmaCarePRICE SENSITIVE11/11/21 download Created with Sketch. 162.56KB
MDC NanoCelle Patent Granted In USAPRICE SENSITIVE04/11/21 download Created with Sketch. 168.05KB
MDC Medlab Receives AusIndustry Overseas (R&D) Finding ApprovalPRICE SENSITIVE03/11/21 download Created with Sketch. 197.12KB
MDC Monthly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/10/21 download Created with Sketch. 433.19KB
MDC PharmaCare Purchases Medab's AUS Only Nutraceutical BusinessPRICE SENSITIVE20/10/21 download Created with Sketch. 178.61KB
MDC Depression Patent for Orotate Approved by US Patent OfficePRICE SENSITIVE08/10/21 download Created with Sketch. 198.87KB
MDC Nanocelle Issued Notice of Allowance by US Patent OfficePRICE SENSITIVE06/10/21 download Created with Sketch. 220.22KB
MDC Appendix 4EPRICE SENSITIVE31/08/21 download Created with Sketch. 80.88KB
MDC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/07/21 download Created with Sketch. 263.47KB
MDC US Patent Office issues Notice of Allowance for NRGBioticPRICE SENSITIVE27/07/21 download Created with Sketch. 227.1KB
MDC Medlab executes Master Services Agreement with WEP ClinicalPRICE SENSITIVE19/07/21 download Created with Sketch. 222.11KB
MDC Australian Ethics Grants Approval for NanaBis PIII AUS SitesPRICE SENSITIVE12/07/21 download Created with Sketch. 207.28KB
MDC Medlab NRGBiotic Depression Study ResultsPRICE SENSITIVE05/07/21 download Created with Sketch. 215.8KB
MDC European and Canadian Patent Offices Grant NanoCelle PatentsPRICE SENSITIVE23/06/21 download Created with Sketch. 189.68KB
MDC Synthetic formulation in pending global PIII TrialPRICE SENSITIVE20/05/21 download Created with Sketch. 169.38KB
MDC Appendix 4C - monthlyPRICE SENSITIVE20/04/21 download Created with Sketch. 391.69KB
MDC Appendix 4C - quarterlyPRICE SENSITIVE20/04/21 download Created with Sketch. 301.67KB
MDC Intention to Grant EU Notice NanoCellePRICE SENSITIVE07/04/21 download Created with Sketch. 198.02KB
MDC Successful Completion of $15 million PlacementPRICE SENSITIVE19/03/21 download Created with Sketch. 665.25KB
MDC Trading HaltPRICE SENSITIVE17/03/21 download Created with Sketch. 753.71KB
MDC Pause in TradingPRICE SENSITIVE17/03/21 download Created with Sketch. 115.1KB
MDC Appendix 4DPRICE SENSITIVE24/02/21 download Created with Sketch. 1.1MB
MDC HOA with Arrotex to accelerate NanoCB access for PharmacyPRICE SENSITIVE18/02/21 download Created with Sketch. 661.16KB
MDC Medlab Receives Positive Depression Trial Prelim ResultsPRICE SENSITIVE11/02/21 download Created with Sketch. 877.6KB
MDC Appendix 4C - quarterlyPRICE SENSITIVE25/01/21 download Created with Sketch. 1.45MB
MDC FDA Grants an IND for NanaBis and Investor WebcastPRICE SENSITIVE19/01/21 download Created with Sketch. 1.11MB
MDC NanaBis P3 Trial Launching in the UK with support from NIHRPRICE SENSITIVE11/11/20 download Created with Sketch. 804.33KB
MDC Appendix 4C - quarterlyPRICE SENSITIVE28/10/20 download Created with Sketch. 3.14MB
MDC Australian Patent Granted for NanoCelle Delivery PlatformPRICE SENSITIVE23/09/20 download Created with Sketch. 1.03MB
MDC Appendix 4EPRICE SENSITIVE28/08/20 download Created with Sketch. 1.07MB
MDC Appendix 4C - quarterlyPRICE SENSITIVE30/07/20 download Created with Sketch. 1.67MB
MDC Medlab Completes First Order of New Cannabinoid to UKPRICE SENSITIVE29/06/20 download Created with Sketch. 696.83KB
MDC Proposed issue of Securities - MDCPRICE SENSITIVE15/06/20 download Created with Sketch. 34.54KB
MDC Medlab Completes Successful $5.4m PlacementPRICE SENSITIVE15/06/20 download Created with Sketch. 726.61KB
MDC NanoCBD Delivery Received and First Patient SuppliedPRICE SENSITIVE11/06/20 download Created with Sketch. 836KB
MDC Trading HaltPRICE SENSITIVE11/06/20 download Created with Sketch. 766.6KB
MDC Appendix 4C - quarterlyPRICE SENSITIVE27/04/20 download Created with Sketch. 1.65MB
MDC MDC Extends NanoCelle Platform to Anti-Malaria DrugPRICE SENSITIVE21/04/20 download Created with Sketch. 720.17KB
MDC Trading HaltPRICE SENSITIVE17/04/20 download Created with Sketch. 752.66KB
MDC Pause in TradingPRICE SENSITIVE17/04/20 download Created with Sketch. 115.24KB
MDC Medlab Executes Nutraceutical HoAPRICE SENSITIVE06/04/20 download Created with Sketch. 680.68KB
MDC Medlab Completes Depression TrialPRICE SENSITIVE01/04/20 download Created with Sketch. 713.56KB
MDC NanaBis PresentationPRICE SENSITIVE09/03/20 download Created with Sketch. 5.72MB
MDC RNSH NanaBis Advanced Cancer Trial ResultsPRICE SENSITIVE09/03/20 download Created with Sketch. 1.03MB
MDC Trading HaltPRICE SENSITIVE05/03/20 download Created with Sketch. 752.61KB
MDC Appendix 4DPRICE SENSITIVE26/02/20 download Created with Sketch. 241.16KB
MDC Formal Launch of the NanaBIs Observational StudyPRICE SENSITIVE04/02/20 download Created with Sketch. 725.41KB
MDC Appendix 4C - quarterlyPRICE SENSITIVE31/01/20 download Created with Sketch. 1.55MB
MDC Agreement Signed with Tasmanian Alkaloids Pty LtdPRICE SENSITIVE29/01/20 download Created with Sketch. 684.27KB
MDC Completion of PlacementPRICE SENSITIVE16/12/19 download Created with Sketch. 631.12KB
MDC Trading HaltPRICE SENSITIVE13/12/19 download Created with Sketch. 746.99KB
MDC Medlab Enters into Distribution Agreement in the UKPRICE SENSITIVE12/12/19 download Created with Sketch. 678.63KB
MDC NanaBis Observational Study - Impressive StartPRICE SENSITIVE02/12/19 download Created with Sketch. 791.87KB
MDC Depression Trial UpdatePRICE SENSITIVE19/11/19 download Created with Sketch. 687.01KB
MDC Half Yearly Report and Accounts
15/05/24PRICE SENSITIVE download Created with Sketch. 1.81MB
MDC Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24PRICE SENSITIVE download Created with Sketch. 343.84KB
MDC MDC Annual Report to shareholders
24/04/24PRICE SENSITIVE download Created with Sketch. 2.1MB
MDC Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24PRICE SENSITIVE download Created with Sketch. 340.71KB
MDC Medlab Settlement of Share Sale Deed
15/01/24PRICE SENSITIVE download Created with Sketch. 121.56KB
MDC MDC HY23 Interim Report
09/01/24PRICE SENSITIVE download Created with Sketch. 510.57KB
MDC Quarterly Activities/Appendix 4C Cash Flow Report
08/12/23PRICE SENSITIVE download Created with Sketch. 1.09MB
MDC Notice of Extraordinary General Meeting / Proxy Form
22/11/23PRICE SENSITIVE download Created with Sketch. 3.2MB
MDC Shareholder Update - Restructuring Transaction
09/11/23PRICE SENSITIVE download Created with Sketch. 170.22KB
MDC Medlab Update to Shareholders
12/09/23PRICE SENSITIVE download Created with Sketch. 133.98KB
MDC Medlab Update to Shareholders
07/06/23PRICE SENSITIVE download Created with Sketch. 101.01KB
MDC Medlab Update to Shareholders
21/03/23PRICE SENSITIVE download Created with Sketch. 372.95KB
MDC Company Status and Board Composition Updates
16/03/23PRICE SENSITIVE download Created with Sketch. 191.22KB
MDC Appointment of External Consultants to Medlab
06/03/23PRICE SENSITIVE download Created with Sketch. 174.6KB
MDC Suspension from Official Quotation
27/02/23PRICE SENSITIVE download Created with Sketch. 86.43KB
MDC Trading Halt
23/02/23PRICE SENSITIVE download Created with Sketch. 438.74KB
MDC Aust ODC Approves NanaDol Export for UK Use
07/02/23PRICE SENSITIVE download Created with Sketch. 152.61KB
MDC Appendix 4C Administrative Clarification
01/02/23PRICE SENSITIVE download Created with Sketch. 385.58KB
MDC UK Home Office Grants UK Import Certificate for NanaBis
25/01/23PRICE SENSITIVE download Created with Sketch. 155.87KB
MDC Quarterly Activities/Appendix 4C Cash Flow Report
20/01/23PRICE SENSITIVE download Created with Sketch. 381.06KB
MDC Medlab Announces Interim Readout of RWE Medcare Study
12/01/23PRICE SENSITIVE download Created with Sketch. 208.1KB
MDC Medlab Files Registration Statement for Proposed US IPO
28/12/22PRICE SENSITIVE download Created with Sketch. 173.82KB
MDC NASDAQ Progression - Medlab Clears SEC Comments
08/12/22PRICE SENSITIVE download Created with Sketch. 151.76KB
MDC First Tranche IP Royalty Payment from Pharmacare
01/12/22PRICE SENSITIVE download Created with Sketch. 149.5KB
MDC Medlab receives UK Import Permission from MHRA for NanaBis
25/11/22PRICE SENSITIVE download Created with Sketch. 169.13KB
MDC Jefferies HealthCare Conference NanoCelle Presentation
16/11/22PRICE SENSITIVE download Created with Sketch. 11.15MB
MDC NanoCelle Nasal RNA (Nucleid Acid) Program Update
10/11/22PRICE SENSITIVE download Created with Sketch. 158.76KB
MDC Quarterly Activities/Appendix 4C Cash Flow Report
28/10/22PRICE SENSITIVE download Created with Sketch. 403.82KB
MDC Medlab Received 2022 R&D Claim
26/09/22PRICE SENSITIVE download Created with Sketch. 162.59KB
MDC Preliminary Final Report
30/08/22PRICE SENSITIVE download Created with Sketch. 99.26KB
MDC Depression European Patent Accepted, Proceeding to Grant
10/08/22PRICE SENSITIVE download Created with Sketch. 201.84KB
MDC UNSW Medlab Laboratory Collaboration Additional Information
02/08/22PRICE SENSITIVE download Created with Sketch. 195.48KB
MDC Medlab enters Laboratory Collaboration with UNSW, Sydney
01/08/22PRICE SENSITIVE download Created with Sketch. 153.33KB
MDC Quarterly Activities/Appendix 4C Cash Flow Report
29/07/22PRICE SENSITIVE download Created with Sketch. 387.97KB
MDC EGM Notice of Meeting to Approve Dual Listing to Nasdaq
29/06/22PRICE SENSITIVE download Created with Sketch. 1.05MB
MDC Trading Halt
28/06/22PRICE SENSITIVE download Created with Sketch. 326.8KB
MDC Pause in Trading
28/06/22PRICE SENSITIVE download Created with Sketch. 116.07KB
MDC NanaBis Independently Confirmed BioAvailability
27/06/22PRICE SENSITIVE download Created with Sketch. 227.72KB
MDC Medlab signs exclusive commercial agreement with YesHealth
23/06/22PRICE SENSITIVE download Created with Sketch. 136.24KB
MDC Progression of NanoCelle NASAL COVID-19 Vaccine Program
31/05/22PRICE SENSITIVE download Created with Sketch. 181.7KB
MDC Medlab Signs NRG Biotic Trade Deal with Cultech Ltd
20/04/22PRICE SENSITIVE download Created with Sketch. 201.69KB
MDC Quarterly Activities/Appendix 4C Cash Flow Report
14/04/22PRICE SENSITIVE download Created with Sketch. 3.62MB
MDC Quarterly Activities/Appendix 4C Cash Flow Report
13/04/22PRICE SENSITIVE download Created with Sketch. 3.38MB
MDC Half Yearly Report and Accounts
24/02/22PRICE SENSITIVE download Created with Sketch. 626.22KB
MDC UK Ethics favourable opinion for upcoming NanaBis P3 Trial
07/02/22PRICE SENSITIVE download Created with Sketch. 191.1KB
MDC Quarterly Activities/Appendix 4C Cash Flow Report
27/01/22PRICE SENSITIVE download Created with Sketch. 420.9KB
MDC Medlab Completes Nutraceuticals Divestment to PharmaCare
11/11/21PRICE SENSITIVE download Created with Sketch. 162.56KB
MDC NanoCelle Patent Granted In USA
04/11/21PRICE SENSITIVE download Created with Sketch. 168.05KB
MDC Medlab Receives AusIndustry Overseas (R&D) Finding Approval
03/11/21PRICE SENSITIVE download Created with Sketch. 197.12KB
MDC Monthly Activities/Appendix 4C Cash Flow Report
29/10/21PRICE SENSITIVE download Created with Sketch. 433.19KB
MDC PharmaCare Purchases Medab's AUS Only Nutraceutical Business
20/10/21PRICE SENSITIVE download Created with Sketch. 178.61KB
MDC Depression Patent for Orotate Approved by US Patent Office
08/10/21PRICE SENSITIVE download Created with Sketch. 198.87KB
MDC Nanocelle Issued Notice of Allowance by US Patent Office
06/10/21PRICE SENSITIVE download Created with Sketch. 220.22KB
MDC Appendix 4E
31/08/21PRICE SENSITIVE download Created with Sketch. 80.88KB
MDC Quarterly Activities/Appendix 4C Cash Flow Report
30/07/21PRICE SENSITIVE download Created with Sketch. 263.47KB
MDC US Patent Office issues Notice of Allowance for NRGBiotic
27/07/21PRICE SENSITIVE download Created with Sketch. 227.1KB
MDC Medlab executes Master Services Agreement with WEP Clinical
19/07/21PRICE SENSITIVE download Created with Sketch. 222.11KB
MDC Australian Ethics Grants Approval for NanaBis PIII AUS Sites
12/07/21PRICE SENSITIVE download Created with Sketch. 207.28KB
MDC Medlab NRGBiotic Depression Study Results
05/07/21PRICE SENSITIVE download Created with Sketch. 215.8KB
MDC European and Canadian Patent Offices Grant NanoCelle Patents
23/06/21PRICE SENSITIVE download Created with Sketch. 189.68KB
MDC Synthetic formulation in pending global PIII Trial
20/05/21PRICE SENSITIVE download Created with Sketch. 169.38KB
MDC Appendix 4C - monthly
20/04/21PRICE SENSITIVE download Created with Sketch. 391.69KB
MDC Appendix 4C - quarterly
20/04/21PRICE SENSITIVE download Created with Sketch. 301.67KB
MDC Intention to Grant EU Notice NanoCelle
07/04/21PRICE SENSITIVE download Created with Sketch. 198.02KB
MDC Successful Completion of $15 million Placement
19/03/21PRICE SENSITIVE download Created with Sketch. 665.25KB
MDC Trading Halt
17/03/21PRICE SENSITIVE download Created with Sketch. 753.71KB
MDC Pause in Trading
17/03/21PRICE SENSITIVE download Created with Sketch. 115.1KB
MDC Appendix 4D
24/02/21PRICE SENSITIVE download Created with Sketch. 1.1MB
MDC HOA with Arrotex to accelerate NanoCB access for Pharmacy
18/02/21PRICE SENSITIVE download Created with Sketch. 661.16KB
MDC Medlab Receives Positive Depression Trial Prelim Results
11/02/21PRICE SENSITIVE download Created with Sketch. 877.6KB
MDC Appendix 4C - quarterly
25/01/21PRICE SENSITIVE download Created with Sketch. 1.45MB
MDC FDA Grants an IND for NanaBis and Investor Webcast
19/01/21PRICE SENSITIVE download Created with Sketch. 1.11MB
MDC NanaBis P3 Trial Launching in the UK with support from NIHR
11/11/20PRICE SENSITIVE download Created with Sketch. 804.33KB
MDC Appendix 4C - quarterly
28/10/20PRICE SENSITIVE download Created with Sketch. 3.14MB
MDC Australian Patent Granted for NanoCelle Delivery Platform
23/09/20PRICE SENSITIVE download Created with Sketch. 1.03MB
MDC Appendix 4E
28/08/20PRICE SENSITIVE download Created with Sketch. 1.07MB
MDC Appendix 4C - quarterly
30/07/20PRICE SENSITIVE download Created with Sketch. 1.67MB
MDC Medlab Completes First Order of New Cannabinoid to UK
29/06/20PRICE SENSITIVE download Created with Sketch. 696.83KB
MDC Proposed issue of Securities - MDC
15/06/20PRICE SENSITIVE download Created with Sketch. 34.54KB
MDC Medlab Completes Successful $5.4m Placement
15/06/20PRICE SENSITIVE download Created with Sketch. 726.61KB
MDC NanoCBD Delivery Received and First Patient Supplied
11/06/20PRICE SENSITIVE download Created with Sketch. 836KB
MDC Trading Halt
11/06/20PRICE SENSITIVE download Created with Sketch. 766.6KB
MDC Appendix 4C - quarterly
27/04/20PRICE SENSITIVE download Created with Sketch. 1.65MB
MDC MDC Extends NanoCelle Platform to Anti-Malaria Drug
21/04/20PRICE SENSITIVE download Created with Sketch. 720.17KB
MDC Trading Halt
17/04/20PRICE SENSITIVE download Created with Sketch. 752.66KB
MDC Pause in Trading
17/04/20PRICE SENSITIVE download Created with Sketch. 115.24KB
MDC Medlab Executes Nutraceutical HoA
06/04/20PRICE SENSITIVE download Created with Sketch. 680.68KB
MDC Medlab Completes Depression Trial
01/04/20PRICE SENSITIVE download Created with Sketch. 713.56KB
MDC NanaBis Presentation
09/03/20PRICE SENSITIVE download Created with Sketch. 5.72MB
MDC RNSH NanaBis Advanced Cancer Trial Results
09/03/20PRICE SENSITIVE download Created with Sketch. 1.03MB
MDC Trading Halt
05/03/20PRICE SENSITIVE download Created with Sketch. 752.61KB
MDC Appendix 4D
26/02/20PRICE SENSITIVE download Created with Sketch. 241.16KB
MDC Formal Launch of the NanaBIs Observational Study
04/02/20PRICE SENSITIVE download Created with Sketch. 725.41KB
MDC Appendix 4C - quarterly
31/01/20PRICE SENSITIVE download Created with Sketch. 1.55MB
MDC Agreement Signed with Tasmanian Alkaloids Pty Ltd
29/01/20PRICE SENSITIVE download Created with Sketch. 684.27KB
MDC Completion of Placement
16/12/19PRICE SENSITIVE download Created with Sketch. 631.12KB
MDC Trading Halt
13/12/19PRICE SENSITIVE download Created with Sketch. 746.99KB
MDC Medlab Enters into Distribution Agreement in the UK
12/12/19PRICE SENSITIVE download Created with Sketch. 678.63KB
MDC NanaBis Observational Study - Impressive Start
02/12/19PRICE SENSITIVE download Created with Sketch. 791.87KB
MDC Depression Trial Update
19/11/19PRICE SENSITIVE download Created with Sketch. 687.01KB
(20min delay)
Last
$6.60
Change
0.000(0.00%)
Mkt cap ! $15.07M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
MDC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.